Nuria Quesada García

Iberia Marketing Manager at Abbott Vascular. All opinions are my own

[Eva Rumiz @EvaRumiz]

New recommendations from the 2024 ESC Guidelines on CCS for INOCA/ANOCA 🔝. @secardiologia @shci_sec @JEscaned @ramonlopezpalop @fer_iver @belcid7 @ErnestoValero84

🥇Coronary función test (CFT) to identify INOCA/ANOCA endotypes: IB

🥈Medical treatment guided by CFT: IIa.

🥉Angina in HFpEF with unobstructred CAD, rule out MVD: IIa.

🎯Definition of endotypes and Specific treatment recommendations

[Niels R. Holm @NielsRHolm]

"Intracoronary imaging guidance by IVUS or OCT is recommended for performing PCI on anatomically complex lesions, in particular left main stem, true bifurcations and long lesions. " EHJ2024
@OctoberTrial @h_evald @GreggWStone @LNAndreasen @ziadalinyc @DrPeterOKane @omeedneghabat @twj1974 @DrKoltowski @mmamas1973 @BURZOTTA_F @dukwoo_park @jcspratt @SimoneBiscaglia @GianlucaCampo78 #imagingfirst #cardiotwitter #ESCcongress2024

[Coroventis Research @coroventis]

Major update to ESC-Guidelines for Chronic Coronary Syndrome (CCS) - emphasis on ANOCA/INOCA patient population and elevation of invasive functional assessment to 1B.

This represent a paradigm shift in the diagnosis and treatment of these patients.

[Abbott Cardiovascular @AbbottCardio]

⚡️Big News w/ #ESCGuidelines OCT-guided PCI & assessing patients for CMD now @ Class 1A & 1B

Abbott leads the way w/ unique solutions to improve patient outcomes
AI-driven #Ultreon for OCT
PressureWire X & CoroFlow for INOCA/ANOCA patients

Safety Info: https://t.co/79Sc3I3skc

[Lorenz Räber, MD PhD @RaberLorenz]

🚨Breaking News: New ESC Guidelines on CCS. Intracoronary Imaging now Class IA for LM, true bifurcation and long lesions!
Either OCT or IVUS. @PCRonline @escardio @NielsRHolm @twj1974 @nicolasamabile @FBiccire @ziadalinyc @hect2701 @sbrugaletta @HolgerNef

[Abbott Cardiovascular @AbbottCardio]

Happening NOW in the #EuroPCR Training Village.

Great to see physicians honing their skills with our AI-driven #IntravascularImaging and exploring the features of our orbital atherectomy technology.

#CardioTwitter

[Abbott Cardiovascular @AbbottCardio]

Large network meta-analysis shared in @theLancet https://t.co/92wUrcg1qL showed for the first time reductions in clinical events demonstrating safety & effectiveness of image-guided PCI
⬇️25% all-cause death
⬇️17% MI
⬇️48% ST
⬇️28% repeat TVR

Safety Info: https://t.co/5IuGQfdcMu

[Abbott Cardiovascular @AbbottCardio]

📰 Late-breaking data at #CRT2024: XIENCE #Stent showed strong performance in patients with single-layer ISR at 1-year: ¹
• 0% cardiac death 
• 0.4% all cause death 
• 1.2% ST 

Learn more & safety Info: https://t.co/qdAGM8V0Rk

[Ziad Ali @ziadalinyc]

This 👇

[Lydia Roca @lydiarocap]

Returning from Barcelona, where we have enjoyed a great course on #MINOCA, masterfully conducted by @josepgomezlara & @egutiMD, with the engaging @twj1974 #FernandoAlfonso @sbrugaletta @javierlopezpais @Dra_IzdoCoronel and other great speakers

[Heartflow @Heartflow]

Join us during ACI 2024 in London on 1/31 from 6-8pm at the Hilton Metropole London, UL. Discover the future of cardiac care with HeartFlow’s interactive session on CCTA+FFRCT at BCIS ACI 2024. Register here: https://t.co/t4UDeS3YTf.
@NickCurzen @ColletCarlos @BCIS_uk

[Antonio Gomez Menchero @AntonioGomezM21]

I curso de Calcio-OCT en HJRJ, Huelva. La formación, la base para abordar las lesiones coronarias mas complejas guiadas por OCT, buscando la excelencia con grandes AMIGOS EXPERTOS. @cardiojsl @AJuradoRoman @CamachoFreire @ElenaIzaga @OscarLa81605851 @Albabfc

[josep @josepgomezlara]

Aun quedan plazas libres para asistir al curso de MINOCA el 2/2/24 en BCN. Expertos nacionales e internacionales nos mostraran los algoritmos diagnosticos para este dx de trabajo y sus causas con la presentacion de 6 casos clinicos. No te lo pierdas! Link: https://t.co/8wyTVJkGsi

[Abbott Cardiovascular @AbbottCardio]

Get a demo of our latest Ultreon 2.0 Software for #OCTimaging at #TCT2023 at Abbott’s booth.

➡️ Sign up to get more info: https://t.co/ysXCKyjJju

#imagefirst

Safety Info: https://t.co/YhSeYUtxzF

[Abbott Cardiovascular @AbbottCardio]

From the latest #OCTimaging clinical data at #ESC2023 to the latest imaging solution—Ultreon 2.0 Software, our AI-enabled IVI software.

3⃣top reasons why you should consider Ultreon Software for your complex PCI.

#imagefirst

Safety Info: https://t.co/YhSeYUtxzF

1/5

[Abbott Cardiovascular @AbbottCardio]

It’s finally OCT-ober 🎃 our special time of the year to highlight 🔑 info about #OCTimaging 💡 for PCI guidance.

This year there’s a lot of new of imaging data post #ESC2023. So let’s dive in, #CardioTwitter. ⬇️

Safety Info: https://t.co/Kt8XiEb8QG
🧵 1/8

[European Society of Cardiology @escardio]

Optical coherence tomography (OCT)-guided percutaneous coronary intervention (PCI) leads to a larger minimum stent area but does not reduce the two-year rate of target vessel failure compared with angiography-guided #PCI ⬇️

#ESCCongress ILUMIEN IV trial

[European Society of Cardiology @escardio]

Optical coherence tomography (#OCT) is non-inferior to intravascular ultrasound (#IVUS) for guiding percutaneous coronary intervention (#PCI) ⬇️

#ESCCongress OCTIVUS trial

[European Society of Cardiology @escardio]

Intravascular imaging-guided percutaneous coronary intervention (PCI) is associated with a lower rate of target lesion failure compared with angiography-guided #PCI ⬇️

#ESCCongress OCT vs. IVUS vs. Angiography Guidance; a real-time updated network meta-analysis

[European Society of Cardiology @escardio]

Percutaneous coronary intervention (#PCI) guided by optical coherence tomography (#OCT) reduces adverse cardiac events in patients with bifurcation lesions ⬇️

#ESCCongress OCTOBER trial